Oncology Market in India: Early Cancer Detection, Precision Oncology & Market Forecast

India Oncology Market Outlook 2026–2034

The India oncology market is experiencing significant growth, driven by the rising incidence of cancer, increasing awareness of early diagnosis, and continuous advancements in cancer treatment technologies. Growing investments in healthcare infrastructure, expanding access to specialized oncology care, and the introduction of targeted therapies and immunotherapies are transforming cancer management across the country. Additionally, government initiatives promoting cancer screening, improved diagnostic capabilities, and increasing adoption of precision medicine are further supporting market expansion.

According to IMARC Group's latest market report, the India oncology market was valued at USD 11.73 Billion in 2025 and is projected to reach USD 30.01 Billion by 2034, exhibiting a compound annual growth rate (CAGR) of 10.45% during the 2026–2034 forecast period. The market's growth is fueled by continuous innovation in oncology therapeutics, rising healthcare expenditure, expanding clinical research activities, and increasing availability of advanced cancer treatment options.

Why Is the Market Growing Rapidly?

1. Rising Burden of Cancer Cases

The increasing prevalence of breast, lung, colorectal, prostate, cervical, and other cancers is driving demand for advanced diagnostic services and effective treatment options. Growing awareness of early detection is also improving treatment outcomes and supporting market growth.

2. Advancements in Targeted Therapies and Immunotherapy

Continuous innovation in targeted therapies, immunotherapy, and precision oncology is revolutionizing cancer treatment. These advanced therapies offer improved efficacy, personalized treatment approaches, and reduced side effects compared to conventional chemotherapy.

3. Expanding Healthcare Infrastructure

The rapid expansion of specialty hospitals, dedicated cancer treatment centers, and advanced diagnostic laboratories is improving access to quality oncology care across India. Investments in modern healthcare facilities continue to strengthen the country's cancer care ecosystem.

4. Increasing Government Support and Cancer Awareness

Government initiatives promoting cancer screening programs, public awareness campaigns, and improved healthcare accessibility are encouraging early diagnosis and timely treatment. These efforts are contributing to higher treatment adoption rates and better patient outcomes.

5. Growth in Clinical Research and Biopharmaceutical Innovation

Pharmaceutical and biotechnology companies are investing heavily in oncology research, clinical trials, and novel drug development. The growing availability of biosimilars, monoclonal antibodies, and next-generation cancer therapies is expanding treatment options for patients.

Get Access to the Business Sample Report

India Oncology Market Segmentation

By Cancer Type:

• Breast Cancer (largest segment)

• Lung Cancer

• Colorectal Cancer

• Prostate Cancer

• Blood Cancer

• Cervical Cancer

• Others

By Therapy:

• Chemotherapy

• Targeted Therapy (leading segment)

• Immunotherapy

• Hormonal Therapy

• Radiation Therapy

• Others

By Drug Class:

• Monoclonal Antibodies

• Checkpoint Inhibitors

• Tyrosine Kinase Inhibitors

• Others

By End User:

• Hospitals (largest segment)

• Specialty Cancer Centers

• Clinics

• Research Institutes

By Distribution Channel:

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

By Region:

• North India

• South India

• East India

• West India

South India dominates the market owing to its advanced healthcare infrastructure, presence of leading oncology hospitals, strong clinical research ecosystem, increasing adoption of advanced cancer therapies, and growing investments in specialized cancer care.

Recent News and Developments

January 2026:

Leading pharmaceutical and biotechnology companies expanded their oncology portfolios through investments in targeted therapies, immunotherapy research, and biosimilar development to improve treatment accessibility and clinical outcomes.

November 2025:

Several healthcare providers strengthened cancer care services by establishing new oncology centers, enhancing diagnostic capabilities, and expanding precision medicine programs to support early diagnosis and personalized treatment.

Note

If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements.